Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100

Journal of Clinical Investigation

Volumn 100, Issue 1, 1997, Pages 180-188

  Véniant, Murielle M ^a,b   Pierotti, Vincenzo ^a   Newland, Dale ^a   Cham, Candace M ^a   Sanan, David A ^a,b   Walzem, Rosemary L ^c   Young, Stephen G ^a,b,d  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apo E deficiency; Body weight; Lipoproteins; Morphometric lesion analysis; Triglyceride

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; HYPERLIPOPROTEINEMIA TYPE 3; LIPOPROTEIN SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0242695290     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119511     Document Type: Article

References (34)

1. Havel, R.J., and J.P. Kane. 1995. Introduction: structure and metabolism of plasma lipoproteins. In The Metabolic and Molecular Bases of Inherited Disease. 7th ed., Vol. 2. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 1841-1851.
2. Young, S.G. 1990. Recent progress in understanding apolipoprotein B. Circulation. 82:1574-1594.
3. Nielsen, L.B., S. Slender, M. Jauhiainen, and B.G. Nordestgaard. 1996. Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. J. Clin. Invest. 98:563-571.
4. Steinberg, D., S. Parthasarathy, T.E. Carew, T.C. Khoo, and J.L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-924.
5. Henriksen, T., E.M. Mahoney, and D. Steinberg. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78:6499-6503.
6. Quinn, M.T., S. Parthasarathy, and D. Steinberg. 1985. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82: 5949-5953.
7. Cushing, S.D., J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab, F. Parhami, R. Gerrity, C.J. Schwartz, and A.M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:5134-5138.
8. Weisgraber, K.H., and S.C. Rall, Jr. 1987. Human apolipoprotein B-100 heparin-binding sites. J. Biol. Chem. 262:11097-11103.
9. Zilversmit, D.B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60:473-485.
10. Mahley, R.W. 1981. The role of dietary fat and cholesterol in atherosclerosis and lipoprotein metabolism. West. J. Med. 134:34-42.
11. Bergeron, N., and R.J. Havel. 1996. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein ε4 allele. J. Clin. Invest. 97:65-72.
12. Purcell-Huynh, D.A., R.V. Farese, Jr., D.F. Johnson, L.M. Flynn, V. Pierotti, D.L. Newland, M.F. Linton, D.A. Sanan, and S.G. Young. 1995. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J. Clin. Invest. 95-2246-2257.
13. Callow, M.J., J. Verstuyft, R. Tangirala, W. Palinski, and E.M. Rubin. 1995. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J. Clin. Invest. 96:1639-1646.
14. Nakashima, Y., A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
15. Reddick, R.L., S.H. Zhang, and N. Maeda. 1994. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb. 14:141-147.
16. Ishibashi, S., J.L. Goldstein, M.S. Brown, J. Herz, and D.K. Burns. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93:1885-1893.
17. Purcell-Huynh, D.A., A. Weinreb, L.W. Castellani, M. Mehrabian, M.H. Doolittle, and A.J. Lusis. 1995. Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach. J. Clin. Invest. 96:1845-1858.
18. Farese, R.V., Jr., M.M. Véniant, C.M. Cham, L.M. Flynn, V. Pierotti, J.F. Loring, M. Traber, S. Ruland, R.S. Stokowski, D. Huszar, and S.G. Young. 1996. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc. Natl. Acad. Sci. USA. 93:6393-6398.
19. Piedrahita, J.A., S.H. Zhang, J.R. Hagaman, P.M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:4471-4475.
20. McCormick, S.P.A., J.K, Ng, M. Véniant, J. Borén, V. Pierotti, L.M. Flynn, D.S. Grass, A. Connolly, and S.G. Young. 1996. Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural gene. J. Biol. Chem. 271:11963-11970.
21. Farese, R.V., Jr., S.L. Ruland, L.M. Flynn, R.P. Stokowski, and S.G. Young. 1995. Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc. Natl. Acad. Sci. USA. 92:1774-1778.
22. Walzem, R.L., P.A. Davis, and R.J. Hansen. 1994. Overfeeding increases very low density lipoprotein diameter and causes the appearance of a unique lipoprotein particle in association with failed yolk deposition. J. Lipid Res. 35:1354-1366.
23. Hamilton, R.L. 1969. Ultrastructural aspects of hepatic lipoprotein synthesis and secretion. In Proceedings of the 1968 Deuel Conference on Lipids on the Turnover of Lipids and Lipoproteins. G. Cowgill, D.L. Estrich, and P.D. Wood, editors. U.S. Department of Health, Education, and Welfare, Bethesda, MD. 3-31.
24. Forte, T., and A.V. Nichols. 1972. Application of electron microscopy to the study of plasma lipoprotein structure. Adv. Lipid Res. 10:1-41.
25. γ mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone. Arterioscler. Thromb. 13:302-309.
26. Tangirala, R.K., E.M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36:2320-2328.
27. The Expert Panel. 1988. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch. Intern. Med. 148:36-69.
28. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P. Holmes. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57:65-73.
29. Paigen, B., B.Y. Ishida, J. Verstuyft, R.B. Winters, and D. Albee. 1990. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 10:316-323.
30. Krul, E.S., M.J. Tikkanen, T.G. Cole, J.M. Davie, and G. Schonfeld. 1985. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J. Clin. Invest. 75:361-369.
31. Ishibashi, S., M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
32. Ishibashi, S., J. Herz, N. Maeda, J.L. Goldstein, and M.S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA. 91:4431-4435.
33. Hirano, K.-I., S.G. Young, R.V. Farese, Jr., J. Ng, E. Sande, C. Warburton, L.M. Powell-Braxton, and N.O. Davidson. 1996. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271:9887-9890.
34. Hollis, N.E. 1990. A statistical approach for calculating the minimum number of animals needed in research. ILAR News. 32:11-16.